Wasatch Advisors Inc Arvinas, Inc. Transaction History

Wasatch Advisors Inc

$20.1 Billion
Q3 2024

A detailed history of Wasatch Advisors Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 435,943 shares of ARVN stock, worth $10.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

435,943

Previous 275,433 58.28%

Holding current value

$10.7 Million

Previous $7.33 Million 46.44%

% of portfolio

0.05%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $3.8 Million - $5.25 Million	160,510 Added 58.28%	435,943 $10.7 Million
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $1.66 Million - $2.75 Million	68,007 Added 32.79%	275,433 $7.33 Million
Q1 2024 Apr 18, 2024	SELL	$36.38 - $52.31 $564,472 - $811,641	-15,516 Reduced 6.96%	207,426 $8.56 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $230,346 - $687,142	16,233 Added 7.85%	222,942 $9.18 Million
Q3 2023 Nov 14, 2023	SELL	$19.64 - $28.21 $1.26 Million - $1.82 Million	-64,351 Reduced 23.74%	206,709 $4.06 Million
Q2 2023 Aug 07, 2023	SELL	$21.73 - $31.43 $15,341 - $22,189	-706 Reduced 0.26%	271,060 $6.73 Million
Q1 2023 May 12, 2023	SELL	$26.15 - $37.26 $18,775 - $26,752	-718 Reduced 0.26%	271,766 $7.42 Million
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $162,901 - $287,173	-5,017 Reduced 1.81%	272,484 $9.32 Million
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $1,632 - $2,261	-39 Reduced 0.01%	277,501 $12.3 Million
Q2 2022 Aug 12, 2022	SELL	$36.01 - $74.24 $3.06 Million - $6.31 Million	-84,957 Reduced 23.44%	277,540 $11.7 Million
Q1 2022 May 13, 2022	SELL	$60.27 - $81.57 $1.03 Million - $1.4 Million	-17,142 Reduced 4.52%	362,497 $24.4 Million
Q4 2021 Feb 15, 2022	SELL	$65.85 - $96.21 $568,483 - $830,580	-8,633 Reduced 2.22%	379,639 $31.2 Million
Q3 2021 Nov 12, 2021	BUY	$73.2 - $107.87 $6.34 Million - $9.34 Million	86,585 Added 28.7%	388,272 $31.9 Million
Q2 2021 Aug 12, 2021	BUY	$60.45 - $84.26 $2.36 Million - $3.28 Million	38,972 Added 14.83%	301,687 $23.2 Million
Q1 2021 May 10, 2021	BUY	$58.19 - $91.37 $15.3 Million - $24 Million	262,715 New	262,715 $17.4 Million

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.31B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Account

Wasatch Advisors Inc Arvinas, Inc. Transaction History